Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,909,428
-$11,062,624 QoQ
Shares Held
56,297
-65.5% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 82.54613922589125.ToString("F0")%
Shared 0.ToString("F0")%
None 17.453860774108744.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026FMR LLC holds $13,563,639,948 across 34 Diagnostics & Research names. GRAL ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,776,436 | $5,296,941,583 | |
| 2 | DHR |
Danaher Corp /De/
|
22,534,329 | $4,272,508,776 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
3,456,244 | $596,202,089 | |
| 4 | NTRA |
Natera, Inc.
|
2,554,254 | $510,825,254 | |
| 5 | ICLR |
Icon PLC
|
4,174,006 | $461,895,500 | |
| 6 | GH |
Guardant Health, Inc.
|
4,116,081 | $380,202,399 | |
| 7 | LH |
Labcorp Holdings Inc.
|
1,288,411 | $343,760,937 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,850,127 | $315,520,657 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,909,428 | 56,297 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,972,052 | 163,244 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,432,870 | 108,792 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,415,745 | 27,533 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $692,797 | 27,126 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $357,142 | 20,008 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $263,955 | 19,183 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $786,604 | 51,178 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||